The impact of obesity on orthodontic treatment outcome in adolescents: a prospective clinical cohort study.


Journal

European journal of orthodontics
ISSN: 1460-2210
Titre abrégé: Eur J Orthod
Pays: England
ID NLM: 7909010

Informations de publication

Date de publication:
03 04 2021
Historique:
pubmed: 12 5 2020
medline: 27 4 2021
entrez: 12 5 2020
Statut: ppublish

Résumé

This prospective clinical cohort study investigated the potential influence of obesity on orthodontic treatment outcome. A prospective cohort of adolescent patients undergoing routine fixed appliance treatment were recruited into normal-weight or obese groups based upon body mass index (BMI) centile and followed up until the completion of treatment. Primary outcome was treatment duration, and secondary outcomes included treatment outcome (occlusal change measured using peer assessment rating [PAR]), appointment characteristics, and compliance measures. A total of 45 patients mean age 14.8 (1.6) years were included in the final analysis. The normal-weight group included 23 patients with mean BMI 19.4 (2.4) kg/m2 and the obese group 22 patients with mean BMI 30.5 (3.8) kg/m2. There were no significant differences in baseline demographics between groups, except for BMI and pre-treatment PAR. The normal-weight group had a mean pre-treatment PAR of 25.6 (8.3) and the obese 33.3 (11.8) giving the obese group a more severe pre-treatment malocclusion (P = 0.02). There were no significant differences in treatment duration between groups (P = 0.36), but obese patients needed less time per each additional baseline PAR point compared to normal weight (P = 0.02). Obese patients also needed less appointments compared to normal-weight patients (P = 0.02). There were no significant differences between groups for appointment characteristics or compliance. Finally, obese patients were more likely to experience a great PAR reduction than normal-weight patients (relative risk = 2.6; 95% confidence interval = 1.2-4.2; P = 0.02). There were no significant differences in treatment duration between obese and normal-weight patients. Obesity does not appear to be a risk factor for negative orthodontic treatment outcome with fixed appliances.

Identifiants

pubmed: 32390057
pii: 5835565
doi: 10.1093/ejo/cjaa032
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

165-172

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the European Orthodontic Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Hayder F Saloom (HF)

Centre for Craniofacial Development and Regeneration, Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK.
Centre for Host-Microbiome Interactions, Department of Mucosal and Salivary Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, UK.
Orthodontic Department, College of Dentistry, University of Baghdad, Iraq.

Roshanak Boustan (R)

Centre for Craniofacial Development and Regeneration, Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK.

Jadbinder Seehra (J)

Centre for Craniofacial Development and Regeneration, Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK.

Spyridon N Papageorgiou (SN)

Clinic of Orthodontics and Pediatric Dentistry, Center of Dental Medicine, University of Zurich, Switzerland.

Guy H Carpenter (GH)

Centre for Host-Microbiome Interactions, Department of Mucosal and Salivary Biology, Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, UK.

Martyn T Cobourne (MT)

Centre for Craniofacial Development and Regeneration, Department of Orthodontics, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH